chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Cough, Pyrexia, Secretion discharge
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 78-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: EN6207), via unspecified route of administration in the left arm on 12Mar2021 at 10:00 (at the age of 78-year-old) as a single dose for COVID-19 immunisation. Medical history included heart disease. The patient was not allergic to medication, food and other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), irbesartan (MANUFACTURER UNKNOWN), hctz (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN), finasterid (MANUFACTURER UNKNOWN) for unknown indication. On 13Mar2021, the patient experienced cough with mucus and fever 99.3 in the morning. It was reported that the patient did not receive treatment for the event. The clinical outcome of the events cough and fever were resolving.   No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site erythema
Clinical narrative: injection site pain; tiredness; headache; muscle pain; chills; joint pain; fever; injection site swelling; injection site redness; swollen lymph node; feeling unwell; This is a spontaneous report received from a non-contactable consumer, the patient. A 70-years-old non pregnant female patient received first dose of BNT162B2 (COVID-19 mRNA VACCINE BIONTECH; lot number: EN6206) via an unspecified route of administration in right arm on 10Mar2021 at 14:15 as a single dose for COVID 19 immunisation. The patient past medical history was breast cancer and patient had fruit allergy Kiwi. The concomitant medications were included Pravastatin (MANUFACTURER UNKNOWN) for unknown indication and unknown date and unknown if ongoing, Amlodipine-Benazepril (MANUFACTURER UNKNOWN) for unknown indication and unknown date and unknown if ongoing, Levothyroxine (MANUFACTURER UNKNOWN) for unknown indication and unknown date and unknown if ongoing. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. On 11Mar2021, at 10.00 the patient experienced on injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, swollen lymph node and feeling unwell. The clinical outcome for the events injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, swollen lymph node and feeling unwell was resolved.   No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Malaise, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: injection site pain; tiredness; headache; muscle pain; chills; joint pain; fever; injection site swelling; injection site redness; swollen lymph node; feeling unwell; This is a spontaneous report received from a non-contactable consumer, the patient. A 70-years-old non pregnant female patient received first dose of BNT162B2 (COVID-19 mRNA VACCINE BIONTECH; lot number: EN6206) via an unspecified route of administration in right arm on 10Mar2021 at 14:15 as a single dose for COVID 19 immunisation. The patient past medical history was breast cancer and patient had fruit allergy Kiwi. The concomitant medications were included Pravastatin (MANUFACTURER UNKNOWN) for unknown indication and unknown date and unknown if ongoing, Amlodipine-Benazepril (MANUFACTURER UNKNOWN) for unknown indication and unknown date and unknown if ongoing, Levothyroxine (MANUFACTURER UNKNOWN) for unknown indication and unknown date and unknown if ongoing. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. On 11Mar2021, at 10.00 the patient experienced on injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, swollen lymph node and feeling unwell. The clinical outcome for the events injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, swollen lymph node and feeling unwell was resolved.   No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: injection site pain; tiredness; headache; muscle pain; chills; joint pain; fever; injection site swelling; injection site redness; swollen lymph node; feeling unwell; This is a spontaneous report received from a non-contactable consumer, the patient. A 70-years-old non pregnant female patient received first dose of BNT162B2 (COVID-19 mRNA VACCINE BIONTECH; lot number: EN6206) via an unspecified route of administration in right arm on 10Mar2021 at 14:15 as a single dose for COVID 19 immunisation. The patient past medical history was breast cancer and patient had fruit allergy Kiwi. The concomitant medications were included Pravastatin (MANUFACTURER UNKNOWN) for unknown indication and unknown date and unknown if ongoing, Amlodipine-Benazepril (MANUFACTURER UNKNOWN) for unknown indication and unknown date and unknown if ongoing, Levothyroxine (MANUFACTURER UNKNOWN) for unknown indication and unknown date and unknown if ongoing. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. On 11Mar2021, at 10.00 the patient experienced on injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, swollen lymph node and feeling unwell. The clinical outcome for the events injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, swollen lymph node and feeling unwell was resolved.   No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Chills, Headache, Heart rate increased
Clinical narrative: vomiting; high pulse 112; upset stomach; chills; shaking; Weakness; headache; This is a spontaneous report from a non- contactable consumer, the patient. This report received from a 70-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number:  Unknown) administered in right arm on 15Mar2021 at 08:45, as a single dose of COVID-19 immunisation. The patient had medical history of GERD and glaucoma. Patient is not known to allergies. The concomitant medications include esomeprazole magnesium (NEXIUM) for an unknown indication. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19.   The patient experienced chills, shaking at 8:00 PM, stomach upset and high pulse 112 (normal pulse for me is 83) at 10:00 PM, which continued until about 10:00 AM, vomiting at 11:00 PM continued to about 2:00 AM, and also experienced weakness and headache on 15Mar2021. The clinical outcome of chills, shakes, stomach upset, high pulse, vomiting, weakness, headache were resolved on an unknown date.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Viral test, Vomiting
Clinical narrative: vomiting; high pulse 112; upset stomach; chills; shaking; Weakness; headache; This is a spontaneous report from a non- contactable consumer, the patient. This report received from a 70-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number:  Unknown) administered in right arm on 15Mar2021 at 08:45, as a single dose of COVID-19 immunisation. The patient had medical history of GERD and glaucoma. Patient is not known to allergies. The concomitant medications include esomeprazole magnesium (NEXIUM) for an unknown indication. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19.   The patient experienced chills, shaking at 8:00 PM, stomach upset and high pulse 112 (normal pulse for me is 83) at 10:00 PM, which continued until about 10:00 AM, vomiting at 11:00 PM continued to about 2:00 AM, and also experienced weakness and headache on 15Mar2021. The clinical outcome of chills, shakes, stomach upset, high pulse, vomiting, weakness, headache were resolved on an unknown date.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Musculoskeletal stiffness, Nausea, Pyrexia
Clinical narrative: Headache; Nausea; Vomiting; Injection site pain; Stiffness in injection limb; Mild fever (100.2 F); This is a spontaneous report from a contactable consumer, the patient. A 19-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER- BIONTECH COVID-19 mRNA Vaccine, lot number: UNKNOWN), via an unspecified route of administration in the left arm on 17Mar2021 at 14:15 (at the age of 19-years-old), as a single dose for COVID-19 immunisation. Medical history included Idiopathic intracranial hypertension, Tourettes and fibromyalgia. Concomitant medications included naproxen (MANUFACTURER UNKNOWN), TOPAMAX, CYMBALTA, ATIVAN and trazodone (MANUFACTURER UNKNOWN) taken for unknown indications from unknown dates within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not tested for COVID-19. On 18Mar2021 at 12:00, the patient experienced headache, nausea, vomiting, injection site pain, stiffness in injection limb and mild fever (100.2 F). No therapeutic measures were taken for the adverse events. The clinical outcome of headache, nausea, vomiting, injection site pain, stiffness in injection limb, mild fever (100.2 F) was recovering/ resolving.   Information about lot number cannot be obtained. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting
Clinical narrative: Headache; Nausea; Vomiting; Injection site pain; Stiffness in injection limb; Mild fever (100.2 F); This is a spontaneous report from a contactable consumer, the patient. A 19-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER- BIONTECH COVID-19 mRNA Vaccine, lot number: UNKNOWN), via an unspecified route of administration in the left arm on 17Mar2021 at 14:15 (at the age of 19-years-old), as a single dose for COVID-19 immunisation. Medical history included Idiopathic intracranial hypertension, Tourettes and fibromyalgia. Concomitant medications included naproxen (MANUFACTURER UNKNOWN), TOPAMAX, CYMBALTA, ATIVAN and trazodone (MANUFACTURER UNKNOWN) taken for unknown indications from unknown dates within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not tested for COVID-19. On 18Mar2021 at 12:00, the patient experienced headache, nausea, vomiting, injection site pain, stiffness in injection limb and mild fever (100.2 F). No therapeutic measures were taken for the adverse events. The clinical outcome of headache, nausea, vomiting, injection site pain, stiffness in injection limb, mild fever (100.2 F) was recovering/ resolving.   Information about lot number cannot be obtained. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Severe itching on arms, back, head (not the face); This is a spontaneous report received from a contactable consumer, the patient. A 72-year-old non- pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; batch no: En6199 Dose number: 1) via unspecified route of administration in the right arm on 09Mar2021 09:00hours as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to COVID vaccination. The patients concomitant medication included 70/30 insulin, lisinopril (MANUFACTURER UNKNOWN), low-dose asprin (MANUFACTURER UNKNOWN), flonase (MANUFACTURER UNKNOWN) taken for unknown indication from an unknown date. Medical history included diabetes, bronchitis/COPD, arthritis. The patient had allergies to penicillin, morphine, fentadoyl, iodine/shellfish. On 09Mar2021 at 11:00 hours, the patient experienced severe itching on arms, back, head (not the face). Therapeutic measures were taken for the events with Certazine (Zyrtec). The clinical outcome of the event severe itching on arms, back, head (not the face) were reported as recovered on an unknown date at the time of this report.  No follow-up attempts possible. No further information expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain
Clinical narrative: Body aches; chills; This is a spontaneous report from a contactable consumer (patient)  A 50-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL3247), via an unspecified route of administration in Arm Left on 16Mar2021 at 11:00 (at 50 years)as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  No allergies to medications, food, or other products . Prior to vaccination and since the vaccination the patient was not diagnosed with COVID-19. Previously on 25Feb2021 at 13:00  (at 50 years)patient took first dose of the vaccine (lot EL3247 )  in right arm for covid-19 immunisation.On 16Mar2021 at 22:00 the patient experienced body aches and chills. No treatment given. The outcome of the events was recovered on an unknown date in 2021.No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on Elbows and Knees.; This is a spontaneous report from a contactable consumer. A 65-years-old-male patient received dose 1 as single of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201,) (at the age of 65-years-old)  on 23Feb2021 and 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) on 17Mar2021 at 03:30 PM, both doses via an unspecified route of administration into left arm for COVID-19 immunisation. Medical history of the patient includes bladder cancer, renal cell carcinoma, heart disease and chronic kidney disease from an unknown date. No concomitant medications were reported. The patient had an allergy towards Egg yolk. Prior to vaccination and since the vaccination the patient had not been diagnosed with COVID-19. The patient experienced rash on elbows and knees on 07Mar2021.The outcome of the event patient was not resolved. No follow-up attempts are possible, no further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain
Clinical narrative: Notable ear pain (like an ear ache) in the same ear on the side I got the shot; This is a spontaneous report from non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) , via an unspecified route of administration in left arm on 17Mar2021 at 10:00 (at the age of 44-year-old )as a single dose dose for COVID-19 immunisation. The patients medical history was not reported. Concomitant medications included HRT. The patient did not have any allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. On17Mar2021 at 19:00,patient experienced ear ache. The clinical outcome of the ear ache was not recovered. Therapeautic measures were taken as a result of event and included Advil at the time of reporting. Information about lot number cannot be obtained. No further information is expected
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer (patient)   A 30-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 16Mar2021 02:30 (Batch/Lot Number: EL3247) (at the age of 30) as single dose for covid-19 immunisation. The first dose was received on 23Feb2021 03:15 PM in Arm left, Batch/Lot number: EL3247 (at the age of 30). Medical history included anxiety, Raynaud's phenomenon. Concomitant medication included nifedipine taken for an unspecified indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced arm pain on 17Mar2021 09:00, headache on 17Mar2021 09:00, chills on 17Mar2021 09:00, fatigue on 17Mar2021 09:00. No treatment received. The events recovered in Mar2021.    No follow-up attempts are possible. No further information is expected
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Persistent hives for past 2 weeks on arms, legs, trunk; This is a spontaneous report from a contactable nurse. A 41-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER COVID-19 mRNA VACCINE BIONTECH, Lot number: EL9261) via an intramuscular route of administration on the left arm on 12Feb2021 at 15:00 hours as a single dose for COVID-19 immunisation. The patients medical history included allergic to PCN (Penicillin). The patients past drug history included the first dose of BNT162B2 (PFIZER COVID-19 mRNA VACCINE BIONTECH, Lot number: EL3247) via an intramuscular route of administration on the left arm on 22Janb2021 at 15:45 hours as a single dose for COVID-19 immunisation. Since the vaccination, the patient was not tested positive for COVID-19. Concomitant medications included pantoprazole (PROTONIX), cetirizine (ZYRTEC), montelukast sodium (SINGULAIR), fluticasone propionate/salmeterol (ADVAIR) all for unknown indications. On 04Mar2021 the patient experienced hives which were persistent for the past 2 weeks on arms, legs and trunk. No therapeutic measures were taken as a result of the event hives. The clinical outcome of the event hives was not recovered at the time of the report.   No follow-up attempts are possible, No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Feeling abnormal
Clinical narrative: right arm was very sore; feeling horrible; Body aches; headache; joint pain; nausea; tired; chills; fever (100.4); muscles ached; This is a spontaneous report received from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6199), via an unspecified route of administration in the right arm on 13Mar2021 at 10:00 AM (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications include cholesterol off (not codable) (MANUFACTURER UNKNOWN), vitamin c (MANUFACTURER UNKNOWN), vitamin d3 (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN). The patient experienced sore right arm, slept on her left side on 13Mar2021 at 16.00, woke up feeling horrible, body aches, headache, joint pain, nausea, tired, chills, fever (100.4), muscles ache. Patient had taken 2 Tylenol (MANUFACTURER UNKNOWN) as treatment for reported events. The clinical outcome of the events body aches, chills, feeling horrible, fever (100.4), headache, joint pain, muscles ached, nausea, right arm was very sore, tired were resolved.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Pain, Pain in extremity
Clinical narrative: right arm was very sore; feeling horrible; Body aches; headache; joint pain; nausea; tired; chills; fever (100.4); muscles ached; This is a spontaneous report received from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6199), via an unspecified route of administration in the right arm on 13Mar2021 at 10:00 AM (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications include cholesterol off (not codable) (MANUFACTURER UNKNOWN), vitamin c (MANUFACTURER UNKNOWN), vitamin d3 (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN). The patient experienced sore right arm, slept on her left side on 13Mar2021 at 16.00, woke up feeling horrible, body aches, headache, joint pain, nausea, tired, chills, fever (100.4), muscles ache. Patient had taken 2 Tylenol (MANUFACTURER UNKNOWN) as treatment for reported events. The clinical outcome of the events body aches, chills, feeling horrible, fever (100.4), headache, joint pain, muscles ached, nausea, right arm was very sore, tired were resolved.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: right arm was very sore; feeling horrible; Body aches; headache; joint pain; nausea; tired; chills; fever (100.4); muscles ached; This is a spontaneous report received from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6199), via an unspecified route of administration in the right arm on 13Mar2021 at 10:00 AM (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications include cholesterol off (not codable) (MANUFACTURER UNKNOWN), vitamin c (MANUFACTURER UNKNOWN), vitamin d3 (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN). The patient experienced sore right arm, slept on her left side on 13Mar2021 at 16.00, woke up feeling horrible, body aches, headache, joint pain, nausea, tired, chills, fever (100.4), muscles ache. Patient had taken 2 Tylenol (MANUFACTURER UNKNOWN) as treatment for reported events. The clinical outcome of the events body aches, chills, feeling horrible, fever (100.4), headache, joint pain, muscles ached, nausea, right arm was very sore, tired were resolved.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Breath sounds, Breath sounds abnormal, Chest discomfort, Dyspnoea, Investigation
Clinical narrative: Decreased air movement present/Examination of the right-upper field reveals decreased breath sounds and wheezing. Examination of the left-upper field reveals decreased breath sounds and wheezing; wheezing/Tight wheeze in lungs; difficulty breathing/shortness of breath; chest tightness; phlegmy throat; frequent throat clearing; This is a spontaneous report from a non-contactable other health care professional. A 48-year-old female patient received second dose of BNT162B2 via an unspecified route of administration on 17Mar2021 (Lot Number: EN6205) as a single dose for covid-19 immunization. The patient medical history was not reported. Patient previously received 1st dose of BNT162B2 on an unspecified date for COVID-19 immunization. The patient's concomitant medications were not reported. During patient's 15 minute waiting period after the injection on 17Mar2021, the patient began to experience difficulty breathing, and chest tightness and phlegmy throat. Patient complained of frequent throat clearing, chest tightness and shortness of breath. Breath sounds: Decreased air movement present. Examination of the right-upper field reveals decreased breath sounds and wheezing. Examination of the left-upper field reveals decreased breath sounds and wheezing. Decreased breath sounds and wheezing present. No rhonchi or rales. Comments: Tight wheeze in lungs. Events cleared after 2 puffs of albuterol inhaler, symptoms reoccurred within 10 min of use. Treatment included albuterol, antihistamines, oral steroids, water and Pepcid. She had poor follow up response to treatment. Patient discharge and transported to ED by ambulance. The outcome of events was unknown.  No follow up attempts are possible, information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Productive cough, Throat clearing, Wheezing
Clinical narrative: Decreased air movement present/Examination of the right-upper field reveals decreased breath sounds and wheezing. Examination of the left-upper field reveals decreased breath sounds and wheezing; wheezing/Tight wheeze in lungs; difficulty breathing/shortness of breath; chest tightness; phlegmy throat; frequent throat clearing; This is a spontaneous report from a non-contactable other health care professional. A 48-year-old female patient received second dose of BNT162B2 via an unspecified route of administration on 17Mar2021 (Lot Number: EN6205) as a single dose for covid-19 immunization. The patient medical history was not reported. Patient previously received 1st dose of BNT162B2 on an unspecified date for COVID-19 immunization. The patient's concomitant medications were not reported. During patient's 15 minute waiting period after the injection on 17Mar2021, the patient began to experience difficulty breathing, and chest tightness and phlegmy throat. Patient complained of frequent throat clearing, chest tightness and shortness of breath. Breath sounds: Decreased air movement present. Examination of the right-upper field reveals decreased breath sounds and wheezing. Examination of the left-upper field reveals decreased breath sounds and wheezing. Decreased breath sounds and wheezing present. No rhonchi or rales. Comments: Tight wheeze in lungs. Events cleared after 2 puffs of albuterol inhaler, symptoms reoccurred within 10 min of use. Treatment included albuterol, antihistamines, oral steroids, water and Pepcid. She had poor follow up response to treatment. Patient discharge and transported to ED by ambulance. The outcome of events was unknown.  No follow up attempts are possible, information about lot/batch number cannot be obtained.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is spontaneous report from a contactable consumer, the patient. A 74-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199), via an unspecified route of administration in the right arm on 17Mar2021 (at the age of 74-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201), via an unspecified route of administration in the right arm on 24Feb2021 at 08:00, (at the age of 74-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced sore arm on 17Mar2021. The patient did not receive treatment for sore arm. The clinical outcome of sore arm was recovering. No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Itching and rash on left and right  forearms.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EUR87127)as a single dose via unspecified route of administration on 17Mar2021 at 12:00 PM (at the age of 58-year-old) for COVID-19 immunisation. The patient medical history included shrimp and raspberries allergy. Concomitant medications included losartan (MANUFACTURER UNKNOWN), flexeril (MANUFACTURER UNKNOWN), ibuprophen 800 (MANUFACTURER UNKNOWN), clonidine (MANUFACTURER UNKNOWN) had taken within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 at 12:00 PM, the patient experienced itching and rash on left and right forearms, left arm worse than right arm. The patient had received cortisone cream as treatment for the event. The clinical outcome of itching and rash on left and right forearms was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via unspecified route of administration in the left arm on 17Mar2021 at 14:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. The patient had not tested positive for COVID-19 prior or since the vaccination. On 17Mar2021 at 19:00, the patient experienced soreness/pain, fatigue/lethargy and low-grade fever. Treatment was not received for the events. The Clinical outcome of the events soreness/pain, fatigue/lethargy and low-grade fever was resolving at the time of report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pyrexia
Clinical narrative: Mild fever (99.7); chills; fatigue; This is a spontaneous report from a contactable consumer (patient)   A 59-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 16Mar2021 11:00 (Batch/Lot Number: unknown) as single dose (at the age of 59) for covid-19 immunisation. Medical history was none. Concomitant medications included atorvastatin calcium (LIPITOR) taken for an unspecified indication, omeprazole (PROTONIX) taken for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced mild fever (99.7) on 17Mar2021 01:30, chills on 17Mar2021 01:30, fatigue on 17Mar2021 01:30. No treatment received for the adverse events. The patient recovered in Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema of eyelid, Eyelid oedema, Eyelid pain
Clinical narrative: Puffy eyelid; red eyelid; sore eyelid; This is a spontaneous report from a contactable consumer ,patient. A 37-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via unspecified route of administration in the left arm on 17Mar2021 at 14:00 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. Medical history included High cholesterol, Anxiety, Seasonal Allergies started on an unknown date. Concomitant medication included sertraline (UNKNOWN MANUFACTURER), multivitamin (UNKNOWN MANUFACTURER), ezetimibe (ZETIA), cetirizine (ZYRTEC), all for unknown indication from unknown date. The patient did not have allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021 the patient's Right eyelid became very puffy, red, and sore. Half of Upper eyelid towards nose. The patient did not receive treatment for the reported events. The clinical outcome for puffy eyelid, red eyelid, and sore eyelid was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm after first dose; This is a spontaneous report received from a contactable consumer, the patient. A 29-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (Lot number: EP-6955), via an unspecified route of administration on an unknown date (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date, the patient had experienced sore arm after first dose. The clinical outcome of the event sore arm after first dose was unknown. No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Nausea, Pyrexia
Clinical narrative: Fever 39 C; Moderate Chills; Moderate muscle pain; mild nausea; This is a spontaneous report from a contactable consumer, the patient. A 45-years-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 17Mar2021 at 10:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patients medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 24Feb2021 at 10:00 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. The patient did not receive any other medications within 2 weeks of COVID-19 vaccination. Patient had no allergies to medications, food, or other products. Patient had not tested for COVID-19, since the vaccination. The patient experienced fever with temperature 39 degrees Celsius, moderate chills, moderate muscle pain and mild nausea on 18Mar2021. Therapeutic measures were taken as a result of adverse events and included treatment with paracetamol and Ibuprofen. The clinical outcome of the fever with temperature 39 degrees Celsius, moderate chills, moderate muscle pain and mild nausea were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Neck pain, Pain
Clinical narrative: chills; body ache; Neck pain; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received her second dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via unspecified route of administration over the left arm on 17Mar2021 at 12:00 (at the age of 40 -year- old) as a single dose of COVID-19 immunisation. Medical history included hypertension and eosinophilic esophagitis. The patient had previously received her first dose of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE; lot number: unknown) via unspecified route of administration over the left arm on 24Feb2021 at 14:30 for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient had received other medications(unspecified) within 2 weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 at 13:00, the patient had experienced the chills, body ache, neck pain and fatigue. The patient did not receive treatment for the reported events. The clinical outcome of the events chills, body ache, neck pain and fatigue was not resolved.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore at injection site; This is a spontaneous report received from a non contactable consumer, the patient. A 45-year-old male patient received of BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown), via an unspecified route of administration on 18Mar2021 at 09:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patients medical history includes Hypertension from unknown date. Concomitant medications includes Losartan for unknown indication from unknown date. The Patient did not have any allergies to medications, food, or other products. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since the vaccination. The patient experienced Sore at injection site on 18Mar2021 at 15:00. The patient did not receive treatment for the reported event. The clinical outcome of the vaccination site pain was not recovered.   Information about lot/batch number cannot be obtained. No further information expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Oropharyngeal pain
Clinical narrative: Experienced sore throat  several after injection.; Experienced ear pain several after injection.; This is a spontaneous report from a contactable consumer. A 56 year old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch Number: EN6199), via unspecified route of administration on the left arm on 09Mar2021 at 02:00 PM (at the age of 56-years-old) as a single second dose for COVID-19 immunisation. Medical history included allergic to raw apple, almond, peach, nectarine and lactose intolerance from an unknown start date. Past drug history included a first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch Number: UNKNOWN), via unspecified route of administration in the left arm on 16Feb2021 at 01:30 PM as a single first dose for COVID-19 immunisation. Concomitant medications included lipitor (MANUFACTURE UNKNOWN) and advair (MANUFACTURE UNKNOWN) from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. The patient had not tested positive prior or since the vaccination. On 11Mar2021 at 03:30 PM, the patient experienced events sore throat and ear pain after the injection. The Clinical outcomes of events sore throat and ear pain were recovered at the time of reporting.   No follow-up attempts are possible. No further information is expected.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Incredible shortness of breath; This is a spontaneous report from a contactable consumer, the patient. A 20-year male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration, in left arm on 17Mar2021 at 15:45 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medication included Ibuprofen once received for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021 at 12:00, the patient experienced incredible shortness of breath. The adverse event resulted in emergency room/department or urgent care visit. The patient did not receive any treatment for the event. The clinical outcome of the event incredible shortness of breath was not recovered. Information about lot number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle twitching
Clinical narrative: twitch on the left-hand side of my face, ran from my left cheek bone to the left corner of my mouth.; This is a spontaneous report received from a contactable consumer, the patient. A 50-Year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) as a single dose via an unspecified route of administration in her left arm on 10Mar2021 at 12:30(at the age of 50-years-old), for COVID-19 immunisation. The patients medical history included high blood pressure and herpes. Concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had received other medications within 2 weeks of vaccination. The patient had not tested positive for COVID-19 since having the vaccine. The patient had reported no allergies to medications, food or other products. The patient had not diagnosed with COVID-19 prior to vaccination. The patient reported that she did not have any side effects immediately, but she woke up friday morning with a "twitch" on the left-hand side of her face, it ran from her left cheek bone to the left corner of her mouth on 12Mar2021at 07:00 hours. It was just an involuntary spasm on that side of her face, she did not have any drooping, it was just an annoyance, it persisted for about six days, she woke up on the 7th day, and the symptoms had almost completely subsided. The patient did not receive any treatment for the reported events. The clinical outcome of the event twitching was recovering at the time of this report.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Feeling cold, Hyperhidrosis
Clinical narrative: felt cold; sweaty repeatedly; felt weak; This is a spontaneous report received from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207), via an unspecified route of administration on left arm on 16Mar2021 at 11:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. Concomitant medications not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The past drug history includes the first dose of BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9266), via an unspecified route of administration on left arm on 23Feb2021 at 11:15 as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021 at 23:45 evening the patient experienced cold. On an unknown date in Mar2021 the patient experienced sweaty repeatedly through the night. On an unknown date in Mar2021 morning following second dose the patient experienced felt weak all day. No treatments for the adverse event taken. The clinical outcome of the events feeling cold, sweaty repeatedly and felt week was recovered on an unknown date in Mar2021. No follow-up attempts are possible. No further information is expected
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain, Paraesthesia, Stomatitis
Clinical narrative: Many open sores developed in mouth; numbness and tingling in most of myfingers; Some burning pain down thearm that was injected also; tingling in most of myfingers; This is a spontaneous report received from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm in Mar2021 at 14:30 (at the age of 55-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroid, high blood pressure and chronic back pain. The patient had sulfa allergy years ago in his her 20s and had never tried it again. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included oxycodone/acetaminophen (MANUFACTURER UNKNOWN), tizanidine (MANUFACTURER UNKNOWN) and fentanyl patch (MANUFACTURER UNKNOWN), all from unknown dates for unknown indication and unknown if ongoing. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The vaccine was administered in a pharmacy or drug store. On 18Mar2021, the patient had many open sores developed in mouth, while taking a nap and she had no symptoms prior. She also had some numbness and tingling in most of her fingers. There was some burning pain down the arm that was injected also. The patient did not receive any treatment for the events sores mouth, numbness in fingers, pain burning and tingling. The clinical outcome of the events sores mouth, numbness in fingers, pain burning and tingling was not recovered.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: ep695s) via an unspecified route of administration in the left arm on 15Mar2021 at 12:15 (at the age of 50-years) as a single dose for COVID-19 immunisation. Medical history included Vitamin D deficiency, Allergy induced Asthma and Sinus disorder. The patient was allergic to latex, nuts, dust, trees, grasses, certain topical creams, smoke, incense and sprays. Prior to vaccination, the patient was not diagnosed with COVID-19 and was not tested positive for COVID-19 since the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN) and  ALAVERT for Decongestion from an unspecified dates. The patient experienced Tiredness on 15Mar2021 at 17:00 that lasted for two days even with 7.5 hours of sleep and the patient found it hard to fully wake up in the morning the day after the vaccination. The patient did not receive any treatment for Tiredness. The clinical outcome of Tiredness was recovered on 17Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, SARS-CoV-2 test
Clinical narrative: loss of taste; This is a spontaneous report from a contactable consumer. A 47-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6206), via an unspecified route of administration in left arm on 15Mar2021 at 12:00 (at the age of 47-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 18Mar2021 at 06:00, the patient experienced loss of taste. On 18Mar2021, the patient underwent nasal swab test and the result was negative. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event loss of taste was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected